BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750
24 results:

  • 1. CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
    de Vos-Hillebrand L; Fietz S; Hillebrand P; Kulcsár Z; Diop MY; Hollick S; Maas AP; Strieth S; Landsberg J; Dietrich D
    Pigment Cell Melanoma Res; 2024 Mar; 37(2):309-315. PubMed ID: 37975535
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms.
    Lu Z; Li T; Liu C; Zheng Y; Song J
    J Endocrinol Invest; 2023 May; 46(5):927-937. PubMed ID: 36394822
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Recovery in glioblastoma multiforme during inpatient rehabilitation is equivalent in first versus repeat resection: A 10-year retrospective analysis.
    Chowdhury N; Scott C; O'Dell MW
    PM R; 2022 Jan; 14(1):40-45. PubMed ID: 33583134
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rehabilitation therapy for patients with glioma: A PRISMA-compliant systematic review and meta-analysis.
    Zhao K; Yu C; Gan Z; Huang M; Wu T; Zhao N
    Medicine (Baltimore); 2020 Nov; 99(45):e23087. PubMed ID: 33157978
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Comparison of Functional Outcomes between Patients Admitted to Inpatient Rehabilitation after Initial Diagnosis Versus Recurrence of Glioblastoma Multiforme.
    Reilly JM; Gundersen AI; Silver JK; Tan CO; Knowlton SE
    PM R; 2020 Oct; 12(10):975-983. PubMed ID: 32281244
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The pathology of hereditary ovarian tumors].
    Pesce F; Devouassoux-Shisheboran M
    Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development of chimeric and bifunctional antagonists for CLR/ramp receptors.
    Chang CL; Hsu SYT
    PLoS One; 2019; 14(5):e0216996. PubMed ID: 31150417
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
    Shain AH; Joseph NM; Yu R; Benhamida J; Liu S; Prow T; Ruben B; North J; Pincus L; Yeh I; Judson R; Bastian BC
    Cancer Cell; 2018 Jul; 34(1):45-55.e4. PubMed ID: 29990500
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Variables affecting functional improvement in chordoma patients admitted to an inpatient rehabilitation facility: A retrospective review.
    Knowlton SE; Goldstein R; O'Connor KC; Schwab J; Hornicek F; Zafonte R
    J Spinal Cord Med; 2018 May; 41(3):355-360. PubMed ID: 28464722
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial.
    Khan F; Amatya B; Drummond K; Galea M
    J Rehabil Med; 2014 Sep; 46(8):754-60. PubMed ID: 24940656
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival.
    Tang V; Rathbone M; Park Dorsay J; Jiang S; Harvey D
    J Neurol; 2008 Jun; 255(6):820-7. PubMed ID: 18500499
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
    Witze ES; Litman ES; Argast GM; Moon RT; Ahn NG
    Science; 2008 Apr; 320(5874):365-9. PubMed ID: 18420933
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Central neurocytoma: 9 case series and review.
    Chen CM; Chen KH; Jung SM; Hsu HC; Wang CM
    Surg Neurol; 2008 Aug; 70(2):204-9. PubMed ID: 18262625
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spinal cord high grade astrocytoma.
    Cuadrado-Pereira M; Rodriguez-Saenz J; Andujar-Felix J
    Bol Asoc Med P R; 2007; 99(1):60-3. PubMed ID: 17616049
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Interaction of receptor-activity-modifying protein1 with tubulin.
    Kunz TH; Mueller-Steiner S; Schwerdtfeger K; Kleinert P; Troxler H; Kelm JM; Ittner LM; Fischer JA; Born W
    Biochim Biophys Acta; 2007 Aug; 1770(8):1145-50. PubMed ID: 17493758
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of transcriptional modulation of the presenilin 1 gene promoter by ZNF237, a candidate binding partner of the Ets transcription factor ERM.
    Pastorcic M; Das HK
    Brain Res; 2007 Jan; 1128(1):21-32. PubMed ID: 17126306
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation.
    Greenberg E; Treger I; Ring H
    Am J Phys Med Rehabil; 2006 Jul; 85(7):568-73. PubMed ID: 16788387
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
    Hansel DE; Rahman A; House M; Ashfaq R; Berg K; Yeo CJ; Maitra A
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6152-8. PubMed ID: 15448002
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Low-contrast detectability in volume rendering: a phantom study on multidetector-row spiral CT data.
    Shin HO; Falck CV; Galanski M
    Eur Radiol; 2004 Feb; 14(2):341-9. PubMed ID: 14556033
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Differential expression of adrenomedullin and its receptor component, receptor activity modifying protein (ramp) 2 during hypoxia in cultured human neuroblastoma cells.
    Kitamuro T; Takahashi K; Totsune K; Nakayama M; Murakami O; Hida W; Shirato K; Shibahara S
    Peptides; 2001 Nov; 22(11):1795-801. PubMed ID: 11754965
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.